Why is JHS Sven.Lab. falling/rising?

As of 17-Sep, JHS Svendgaard Laboratories Ltd is experiencing a decline in its stock price, currently at 11.02, reflecting a decrease of 0.26 or 2.3%. The stock has underperformed significantly, with a 1-week return of -5.73% and a 1-month return of -2.30%. Today's performance indicates that it has underperformed its sector by 1.97%, and it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The company has a weak long-term fundamental outlook, evidenced by a -5.77% CAGR growth in operating profits over the last five years, a poor EBIT to interest ratio of -8.00, and negative returns on capital employed (ROCE). Furthermore, the stock's performance has been negatively impacted by a significant drop in profits, which have fallen by -623.8% over the past year.
In the broader market context, the Sensex has shown a positive return of 1.56% over the past week, contrasting sharply with JHS Svendgaard's negative performance. This consistent underperformance against the benchmark is notable, as the stock has generated a return of -64.02% over the last year, while the Sensex has only declined by 0.46%. The company's majority shareholders are non-institutional, which may contribute to its volatility. Despite a rise in investor participation, as indicated by a 26.69% increase in delivery volume, the overall sentiment remains bearish due to the company's weak fundamentals and consistent losses.